Episode Details

Today, Kimberly-Clark announced it buys Kenvue. It is actually investing in a Revenue Management transformation. In this week’s episode, we unpack why this $48.7 billion deal isn’t about scale, but about injecting a disciplined Revenue Growth Management (RGM) engine into a very different commercial DNA. From pricing architecture and promotion ROI to pharmacy expansion and digital bundling, the stakes are high. Can Kimberly-Clark’s data-driven machine unlock more value from Tylenol, Listerine, and Neutrogena than Kenvue ever could? Or will it expose the limits of capability transfer? 

FMCG Weekly - News and trends curated by Accuris, the leading independent consultancy for revenue growth management